Colgate Announces 2nd Quarter 2017 Results
Net income and Diluted earnings per share in second quarter 2017 were
Net income and Diluted earnings per share in second quarter 2016 were
Excluding charges resulting from the 2012 Restructuring Program in both
periods and the net benefit related to a previously disclosed foreign
tax matter in 2016, Net income in second quarter 2017 was
Gross profit margin was 60.1% in second quarter 2017 versus 59.9% in second quarter 2016. Excluding charges resulting from the 2012 Restructuring Program in both periods, Gross profit margin was 60.7% in second quarter 2017, an increase of 50 basis points versus the year ago quarter. This increase was primarily driven by cost savings from the Company's funding-the-growth initiatives and the 2012 Restructuring Program, and higher pricing, partially offset by higher raw and packaging material costs, which included foreign exchange transaction costs.
Selling, general and administrative expenses were 34.8% of Net sales in
second quarter 2017 versus 34.3% of Net sales in second quarter 2016.
Excluding charges resulting from the 2012 Restructuring Program in both
periods, Selling, general and administrative expenses increased by 40
basis points to 34.4% of Net sales in second quarter 2017, as a result
of increased advertising investment and higher overhead expenses.
Worldwide advertising investment increased 1% to
Operating profit decreased to
Net cash provided by operations year to date decreased to
"Colgate's leadership of the global toothpaste market continued during the quarter with its global market share now at 43.6% year to date. Our global leadership in manual toothbrushes also continued with Colgate's global market share in that category now at 32.8% year to date.
"As we look ahead, uncertainty in global markets and slowing category growth worldwide remain challenging. Based on current spot rates, we continue to expect a low-single-digit net sales increase for 2017, and given our slower than expected first half, we are now planning for low-single-digit organic sales growth for 2017.
"We are pleased with the progress of our 2012 Restructuring Program, and, as we have previously said, we continue to pursue additional savings opportunities, especially given the current challenging environment. In the second quarter, we identified additional opportunities under our Program that take us to the upper end of our previously disclosed cost and savings ranges. As a result, on a GAAP basis, based on current spot rates, we are planning for a year of gross margin expansion and now expect a mid-single-digit earnings per share percentage decline on a dollar basis.
"Excluding charges resulting from the 2012 Restructuring Program and the other 2016 one-time items previously disclosed, based on current spot rates, we continue to plan for a year of strong operating cash flow, gross margin expansion, increased advertising investment and low-single-digit earnings per share growth on a dollar basis."
At
The following are comments about divisional performance for second quarter 2017 versus the year ago period. See attached Geographic Sales Analysis Percentage Changes and Segment Information tables for additional information on divisional net sales and operating profit.
North America Net sales decreased 3.5% in second quarter 2017. Unit
volume decreased 2.0% with 1.5% lower pricing, while foreign exchange
was even with the year ago quarter. Organic sales for
Operating profit in
In the
New products succeeding in other categories include
Latin America Net sales increased 7.0% in second quarter 2017. Unit
volume increased 2.5% with 4.5% higher pricing, while foreign exchange
was even with the year ago quarter. Volume gains were led by
Operating profit in
Colgate maintained its leadership in toothpaste in
Products in other categories contributing to growth throughout the
region include Colgate Plax Ice Glacial and Colgate Luminous White XD
Shine mouthwashes, Protex Pro-Hidrata shower gel, bar soap and liquid
hand soap, Palmolive Natural Secrets shower gel and bar soap,
Europe Net sales decreased 3.5% in second quarter 2017. Unit volume
decreased 1.0%, pricing increased 0.5% and foreign exchange was negative
3.0%. Volume declines in
Operating profit in
Colgate maintained its oral care leadership in
Premium innovations succeeding in other product categories include
Asia Pacific Net sales decreased 5.0% during second quarter 2017. Unit
volume decreased 2.0%, pricing decreased 1.5% and foreign exchange was
negative 1.5%. Volume declines in
Operating profit in
Colgate continued its toothpaste leadership in the
New products succeeding in other categories in the region include Colgate Slim Soft Advanced, Colgate 360° Advanced and Colgate Peppa Pig™ manual toothbrushes, Colgate Minions™ manual and powered toothbrushes, Colgate Plax Ice Infinity and Colgate Plax Spicy Fresh mouthwashes, Protex Thai Therapy bar soap, Ajax Spray n' Wipe cleaners and Softlan Gentle Care and Softlan Charcoal Cupboard Fresh fabric conditioners.
Operating profit in
Colgate continued its toothpaste leadership in
Hill's Pet Nutrition (15% of Company Sales)
Hill's Net sales were even with the year ago quarter. Unit volume
decreased 1.5% with 2.0% higher pricing, while foreign exchange was
negative 0.5%. Volume declines in
Hill's Operating profit increased 1% in second quarter 2017 to
Successful products contributing to sales in the
Successful products contributing to sales internationally include Hill's
Prescription Diet i/d, Hill's Prescription Diet z/d, Hill's Prescription
Diet k/d with Enhanced Appetite Trigger (
***
About
Market Share Information
Management uses market share information as a key indicator to monitor
business health and performance. References to market share in this
press release are based on a combination of consumption and market share
data provided by third-party vendors, primarily Nielsen, and internal
estimates. All market share references represent the percentage of the
dollar value of sales of our products, relative to all product sales in
the category in the countries in which the Company competes and
purchases data (excluding
Cautionary Statement on Forward-Looking Statements
This press release and the related webcast may contain forward-looking
statements (as that term is defined in the
Non-GAAP Financial Measures
The following provides information regarding the non-GAAP financial measures used in this earnings release and/or the related webcast:
This release discusses Net sales growth (GAAP) and organic sales growth,
which is Net sales growth excluding the impact of foreign exchange,
acquisitions and divestments (non-GAAP). Management believes the organic
sales growth measure provides investors and analysts with useful
supplemental information regarding the Company's underlying sales trends
by presenting sales growth excluding the external factor of foreign
exchange as well as the impact from acquisitions and divestments. See
"Geographic Sales Analysis Percentage Changes" for the three and six
months ended
To supplement Colgate's Condensed Consolidated Statements of Income
presented in accordance with GAAP, the Company has disclosed non-GAAP
measures of operating results that exclude certain items. Worldwide
Gross profit, Gross profit margin, Selling, general and administrative
expenses, Selling, general and administrative expenses as a percentage
of Net sales, Other (income) expense, net, Operating profit, Operating
profit margin, Effective income tax rate, Net income attributable to
The Company uses these financial measures internally in its budgeting process, to evaluate segment and overall operating performance and as factors in determining compensation. While the Company believes that these financial measures are useful in evaluating the Company's underlying business performance and trends, this information should be considered as supplemental in nature and is not meant to be considered in isolation or as a substitute for the related financial information prepared in accordance with GAAP. In addition, these non-GAAP financial measures may not be the same as similar measures presented by other companies.
The Company defines free cash flow before dividends as Net cash provided
by operations less Capital expenditures. As management uses this measure
to evaluate the Company's ability to satisfy current and future
obligations, repurchase stock, pay dividends and fund future business
opportunities, the Company believes that it provides useful information
to investors. Free cash flow before dividends is not a measure of cash
available for discretionary expenditures since the Company has certain
non-discretionary obligations such as debt service that are not deducted
from the measure. Free cash flow before dividends is a non-GAAP measure
and may not be comparable to similarly titled measures reported by other
companies. See "Condensed Consolidated Statements of Cash Flows" for the
six months ended
Explanatory Note Regarding Currency-Neutral Calculations
Diluted earnings per share growth for second quarter 2017, on a
currency-neutral basis, eliminates from Diluted earnings per share
growth (GAAP) charges resulting from the 2012 Restructuring Program, a
net benefit from a previously disclosed foreign tax matter and
period-over-period changes in foreign exchange rates in the translation
of local currency results into
Management's estimate of Diluted earnings per share growth on a
currency-neutral basis for full year 2017 eliminates from Diluted
earnings per share growth (GAAP) the impact of the 2016 items previously
disclosed, charges resulting from the 2012 Restructuring Program, and
period-over-period changes in foreign exchange rates in the translation
of local currency results into
(See attached tables for second quarter results.)
Table 1 | ||||||||||||
|
||||||||||||
Condensed Consolidated Statements of Income | ||||||||||||
For the Three Months Ended |
||||||||||||
(Dollars in Millions Except Per Share Amounts) (Unaudited) | ||||||||||||
2017 | 2016 | |||||||||||
Net sales | $ | 3,826 | $ | 3,845 | ||||||||
Cost of sales | 1,526 | 1,541 | ||||||||||
Gross profit | 2,300 | 2,304 | ||||||||||
Gross profit margin | 60.1 | % | 59.9 | % | ||||||||
Selling, general and administrative expenses | 1,333 | 1,320 | ||||||||||
Other (income) expense, net | 114 | 40 | ||||||||||
Operating profit | 853 | 944 | ||||||||||
Operating profit margin | 22.3 | % | 24.6 | % | ||||||||
Interest (income) expense, net | 24 | 25 | ||||||||||
Income before income taxes | 829 | 919 | ||||||||||
Provision for income taxes | 269 | 281 | ||||||||||
Effective tax rate | 32.4 | % | 30.6 | % | ||||||||
Net income including noncontrolling interests | 560 | 638 | ||||||||||
Less: Net income attributable to noncontrolling interests | 36 | 38 | ||||||||||
Net income attributable to |
$ | 524 | $ | 600 | ||||||||
Earnings per common share | ||||||||||||
Basic | $ | 0.59 | $ | 0.67 | ||||||||
Diluted | $ | 0.59 | $ | 0.67 | ||||||||
Average common shares outstanding | ||||||||||||
Basic | 883.8 | 893.9 | ||||||||||
Diluted | 890.8 | 901.1 | ||||||||||
Table 2 | ||||||||||||
|
||||||||||||
Condensed Consolidated Statements of Income | ||||||||||||
For the Six Months Ended |
||||||||||||
(Dollars in Millions Except Per Share Amounts) (Unaudited) | ||||||||||||
2017 | 2016 | |||||||||||
Net sales | $ | 7,588 | $ | 7,607 | ||||||||
Cost of sales | 3,019 | 3,055 | ||||||||||
Gross profit | 4,569 | 4,552 | ||||||||||
Gross profit margin | 60.2 | % | 59.8 | % | ||||||||
Selling, general and administrative expenses | 2,695 | 2,674 | ||||||||||
Other (income) expense, net | 136 | 67 | ||||||||||
Operating profit | 1,738 | 1,811 | ||||||||||
Operating profit margin | 22.9 | % | 23.8 | % | ||||||||
Interest (income) expense, net | 47 | 53 | ||||||||||
Income before income taxes | 1,691 | 1,758 | ||||||||||
Provision for income taxes | 520 | 546 | ||||||||||
Effective tax rate | 30.8 | % | 31.1 | % | ||||||||
Net income including noncontrolling interests | 1,171 | 1,212 | ||||||||||
Less: Net income attributable to noncontrolling interests | 77 | 79 | ||||||||||
Net income attributable to |
$ | 1,094 | $ | 1,133 | ||||||||
Earnings per common share | ||||||||||||
Basic(1) | $ | 1.24 | $ | 1.27 | ||||||||
Diluted(1) | $ | 1.23 | $ | 1.26 | ||||||||
Average common shares outstanding | ||||||||||||
Basic | 884.2 | 893.8 | ||||||||||
Diluted | 890.9 | 900.7 |
Note: |
(1) Basic and diluted earnings per share are computed independently for each quarter and any year-to-date period presented. As a result of changes in shares outstanding during the year and rounding, the sum of the quarters' earnings per share may not necessarily equal the earnings per share for any year-to-date period. |
Table 3 | ||||||||||||
|
||||||||||||
Condensed Consolidated Balance Sheets | ||||||||||||
As of |
||||||||||||
(Dollars in Millions) (Unaudited) | ||||||||||||
|
|
|
||||||||||
2017 | 2016 | 2016 | ||||||||||
Cash and cash equivalents | $ | 1,241 | $ | 1,315 | $ | 1,085 | ||||||
Receivables, net | 1,526 | 1,411 | 1,575 | |||||||||
Inventories | 1,199 | 1,171 | 1,232 | |||||||||
Other current assets | 589 | 441 | 722 | |||||||||
Property, plant and equipment, net | 3,930 | 3,840 | 3,825 | |||||||||
Other assets, including goodwill and intangibles | 4,095 | 3,945 | 4,076 | |||||||||
Total assets | $ | 12,580 | $ | 12,123 | $ | 12,515 | ||||||
Total debt | $ | 6,519 | $ | 6,533 | $ | 6,572 | ||||||
Other current liabilities | 3,767 | 3,292 | 3,718 | |||||||||
Other non-current liabilities | 2,206 | 2,281 | 2,191 | |||||||||
Total liabilities | 12,492 | 12,106 | 12,481 | |||||||||
|
(242 | ) | (243 | ) | (281 | ) | ||||||
Noncontrolling interests | 330 | 260 | 315 | |||||||||
Total liabilities and equity | $ | 12,580 | $ | 12,123 | $ | 12,515 | ||||||
Supplemental Balance Sheet Information | ||||||||||||
Debt less cash, cash equivalents and marketable securities* | $ | 5,123 | $ | 5,147 | $ | 5,274 | ||||||
Working capital % of sales | (3.9 | )% | (2.2 | )% | (2.6 | )% |
* |
Marketable securities of |
Table 4 | ||||||||||||
|
||||||||||||
Condensed Consolidated Statements of Cash Flows | ||||||||||||
For the Six Months Ended |
||||||||||||
(Dollars in Millions) (Unaudited) | ||||||||||||
2017 | 2016 | |||||||||||
Operating Activities | ||||||||||||
Net income including noncontrolling interests | $ | 1,171 | $ | 1,212 | ||||||||
Adjustments to reconcile net income including noncontrolling interests to net cash provided by operations: | ||||||||||||
Depreciation and amortization | 226 | 215 | ||||||||||
Restructuring and termination benefits, net of cash | 78 | 8 | ||||||||||
Stock-based compensation expense | 53 | 48 | ||||||||||
Deferred income taxes | (64 | ) | (41 | ) | ||||||||
Voluntary benefit plan contribution | (57 | ) | (50 | ) | ||||||||
Cash effects of changes in: | ||||||||||||
Receivables | (64 | ) | (132 | ) | ||||||||
Inventories | 9 | (35 | ) | |||||||||
Accounts payable and other accruals | (61 | ) | 69 | |||||||||
Other non-current assets and liabilities | 14 | 26 | ||||||||||
Net cash provided by operations | 1,305 | 1,320 | ||||||||||
Investing Activities | ||||||||||||
Capital expenditures | (229 | ) | (248 | ) | ||||||||
Purchases of marketable securities and investments | (201 | ) | (183 | ) | ||||||||
Proceeds from sale of marketable securities and investments | 114 | 87 | ||||||||||
Other | 4 | 4 | ||||||||||
Net cash used in investing activities |
(312 | ) | (340 | ) | ||||||||
Financing Activities | ||||||||||||
Principal payments on debt | (1,841 | ) | (4,078 | ) | ||||||||
Proceeds from issuance of debt | 1,761 | 4,123 | ||||||||||
Dividends paid | (716 | ) | (704 | ) | ||||||||
Purchases of treasury shares | (660 | ) | (482 | ) | ||||||||
Proceeds from exercise of stock options | 337 | 274 | ||||||||||
Net cash used in financing activities | (1,119 | ) | (867 | ) | ||||||||
Effect of exchange rate changes on Cash and cash equivalents | 52 | 2 | ||||||||||
Net increase in Cash and cash equivalents | (74 | ) | 115 | |||||||||
Cash and cash equivalents at beginning of the period | 1,315 | 970 | ||||||||||
Cash and cash equivalents at end of the period | $ | 1,241 | $ | 1,085 | ||||||||
Supplemental Cash Flow Information | ||||||||||||
Free cash flow before dividends (Net cash provided by operations less Capital expenditures) | ||||||||||||
Net cash provided by operations | $ | 1,305 | $ | 1,320 | ||||||||
Less: Capital expenditures | (229 | ) | (248 | ) | ||||||||
Free cash flow before dividends | $ | 1,076 | $ | 1,072 | ||||||||
Income taxes paid | $ | 639 | $ | 507 | ||||||||
Table 5 | ||||||||||||||||
|
||||||||||||||||
Segment Information | ||||||||||||||||
For the Three and Six Months Ended |
||||||||||||||||
(Dollars in Millions) (Unaudited) | ||||||||||||||||
Three Months Ended |
Six Months Ended |
|||||||||||||||
2017 | 2016 | 2017 | 2016 | |||||||||||||
|
||||||||||||||||
Oral, Personal and Home Care | ||||||||||||||||
|
$ | 764 | $ | 793 | $ | 1,524 | $ | 1,593 | ||||||||
|
1,002 | 938 | 1,926 | 1,786 | ||||||||||||
|
584 | 606 | 1,142 | 1,194 | ||||||||||||
|
663 | 697 | 1,383 | 1,440 | ||||||||||||
|
241 | 239 | 487 | 470 | ||||||||||||
Total Oral, Personal and Home Care | 3,254 | 3,273 | 6,462 | 6,483 | ||||||||||||
Pet Nutrition | 572 | 572 | 1,126 | 1,124 | ||||||||||||
Total |
$ | 3,826 | $ | 3,845 | $ | 7,588 | $ | 7,607 | ||||||||
Three Months Ended |
Six Months Ended |
|||||||||||||||
2017 | 2016 | 2017 | 2016 | |||||||||||||
Operating Profit | ||||||||||||||||
Oral, Personal and Home Care | ||||||||||||||||
|
$ | 241 | $ | 250 | $ | 474 | $ | 489 | ||||||||
|
308 | 284 | 577 | 531 | ||||||||||||
|
145 | 138 | 285 | 279 | ||||||||||||
|
205 | 219 | 424 | 438 | ||||||||||||
|
45 | 45 | 90 | 88 | ||||||||||||
Total Oral, Personal and Home Care | 944 | 936 | 1,850 | 1,825 | ||||||||||||
Pet Nutrition | 163 | 162 | 320 | 317 | ||||||||||||
Corporate(1) | (254 | ) | (154 | ) | (432 | ) | (331 | ) | ||||||||
Total Operating Profit | $ | 853 | $ | 944 | $ | 1,738 | $ | 1,811 |
Note: |
(1) Corporate operations include costs related to stock options and restricted stock units, research and development costs, Corporate overhead costs, restructuring and related implementation costs and gains and losses on sales of non-core product lines and assets. |
Corporate Operating profit (loss) for the three months ended |
Corporate Operating profit (loss) for the six months ended |
Table 6 | |||||||||||||||||||||
|
|||||||||||||||||||||
Geographic Sales Analysis Percentage Changes | |||||||||||||||||||||
For the Three Months Ended |
|||||||||||||||||||||
(Unaudited) | |||||||||||||||||||||
COMPONENTS OF SALES CHANGE | |||||||||||||||||||||
Pricing | |||||||||||||||||||||
Coupons | |||||||||||||||||||||
Sales | Consumer & | ||||||||||||||||||||
Change | Organic | As Reported | Organic | Ex-Divested | Trade | Foreign | |||||||||||||||
Region |
As Reported |
Sales Change |
Volume (1) |
Volume |
Volume (2) |
Incentives |
Exchange |
||||||||||||||
|
(0.5 | )% | — | % | (1.0 | )% | (1.0 | )% | (1.0 | )% | 1.0 | % | (0.5 | )% | |||||||
|
(3.5 | )% | (0.5 | )% | (1.0 | )% | (1.0 | )% | (1.0 | )% | 0.5 | % | (3.0 | )% | |||||||
|
7.0 | % | 7.0 | % | 2.5 | % | 2.5 | % | 2.5 | % | 4.5 | % | — | % | |||||||
|
(5.0 | )% | (3.5 | )% | (2.0 | )% | (2.0 | )% | (2.0 | )% | (1.5 | )% | (1.5 | )% | |||||||
|
1.0 | % | (3.0 | )% | (7.5 | )% | (7.5 | )% | (7.5 | )% | 4.5 | % | 4.0 | % | |||||||
|
0.5 | % | 1.0 | % | (0.5 | )% | (0.5 | )% | (0.5 | )% | 1.5 | % | (0.5 | )% | |||||||
|
(3.5 | )% | (3.5 | )% | (2.0 | )% | (2.0 | )% | (2.0 | )% | (1.5 | )% | — | % | |||||||
Total CP Products | (0.5 | )% | — | % | (1.0 | )% | (1.0 | )% | (1.0 | )% | 1.0 | % | (0.5 | )% | |||||||
Hill's | — | % | 0.5 | % | (1.5 | )% | (1.5 | )% | (1.5 | )% | 2.0 | % | (0.5 | )% | |||||||
Emerging Markets (3) | 2.5 | % | 2.5 | % | — | % | — | % | — | % | 2.5 | % | — | % | |||||||
Developed Markets | (3.5 | )% | (2.0 | )% | (1.5 | )% | (1.5 | )% | (1.5 | )% | (0.5 | )% | (1.5 | )% |
Notes: |
(1) As Reported Volume includes the impact of acquisitions and divestments, as applicable. |
(2) Ex-Divested Volume excludes the impact of divestments, as applicable. |
(3) Emerging Markets include |
Table 7 | |||||||||||||||||||||
|
|||||||||||||||||||||
Geographic Sales Analysis Percentage Changes | |||||||||||||||||||||
For the Six Months Ended |
|||||||||||||||||||||
(Unaudited) | |||||||||||||||||||||
COMPONENTS OF SALES CHANGE | |||||||||||||||||||||
Pricing | |||||||||||||||||||||
Coupons | |||||||||||||||||||||
Sales | Consumer & | ||||||||||||||||||||
Change | Organic | As Reported | Organic | Ex-Divested | Trade | Foreign | |||||||||||||||
Region |
As Reported |
Sales Change |
Volume (1) |
Volume |
Volume (2) |
Incentives |
Exchange |
||||||||||||||
|
— | % | — | % | (1.5 | )% | (1.5 | )% | (1.5 | )% | 1.5 | % | — | % | |||||||
|
(4.5 | )% | (0.5 | )% | — | % | — | % | — | % | (0.5 | )% | (4.0 | )% | |||||||
|
8.0 | % | 7.0 | % | 1.5 | % | 1.5 | % | 1.5 | % | 5.5 | % | 1.0 | % | |||||||
|
(4.0 | )% | (2.5 | )% | (2.0 | )% | (2.0 | )% | (2.0 | )% | (0.5 | )% | (1.5 | )% | |||||||
|
3.5 | % | (1.0 | )% | (7.0 | )% | (7.0 | )% | (7.0 | )% | 6.0 | % | 4.5 | % | |||||||
|
1.0 | % | 1.5 | % | (0.5 | )% | (0.5 | )% | (0.5 | )% | 2.0 | % | (0.5 | )% | |||||||
|
(4.5 | )% | (4.5 | )% | (3.5 | )% | (3.5 | )% | (3.5 | )% | (1.0 | )% | — | % | |||||||
Total CP Products | (0.5 | )% | — | % | (1.5 | )% | (1.5 | )% | (1.5 | )% | 1.5 | % | (0.5 | )% | |||||||
Hill's | — | % | — | % | (2.5 | )% | (2.5 | )% | (2.5 | )% | 2.5 | % | — | % | |||||||
Emerging Markets (3) | 3.5 | % | 3.0 | % | (0.5 | )% | (0.5 | )% | (0.5 | )% | 3.5 | % | 0.5 | % | |||||||
Developed Markets | (3.5 | )% | (2.5 | )% | (2.5 | )% | (2.5 | )% | (2.5 | )% | — | % | (1.0 | )% |
Notes: |
(1) As Reported Volume includes the impact of acquisitions and divestments, as applicable. |
(2) Ex-Divested Volume excludes the impact of divestments, as applicable. |
(3) Emerging Markets include |
Table 8 | |||||||||||
|
|||||||||||
Non-GAAP Reconciliations | |||||||||||
For the Three Months Ended |
|||||||||||
(Dollars in Millions Except Per Share Amounts) (Unaudited) | |||||||||||
Gross Profit | 2017 | 2016 | |||||||||
Gross profit, GAAP | $ | 2,300 | $ | 2,304 | |||||||
2012 Restructuring Program | 21 | 12 | |||||||||
Gross profit, non-GAAP | $ | 2,321 | $ | 2,316 | |||||||
|
|||||||||||
Gross Profit Margin | 2017 | 2016 | Change | ||||||||
Gross profit margin, GAAP | 60.1 | % | 59.9 | % | 20 | ||||||
2012 Restructuring Program | 0.6 | % | 0.3 | % | |||||||
Gross profit margin, non-GAAP | 60.7 | % | 60.2 | % | 50 | ||||||
Selling, General and Administrative Expenses | 2017 | 2016 | |||||||||
Selling, general and administrative expenses, GAAP | $ | 1,333 | $ | 1,320 | |||||||
2012 Restructuring Program | (17 | ) | (14 | ) | |||||||
Selling, general and administrative expenses, non-GAAP | $ | 1,316 | $ | 1,306 | |||||||
|
|||||||||||
Selling, General and Administrative Expenses as a Percentage of
|
2017 | 2016 | Change | ||||||||
Selling, general and administrative expenses as a percentage of Net sales, GAAP | 34.8 | % | 34.3 | % | 50 | ||||||
2012 Restructuring Program | (0.4 | )% | (0.3 | )% | |||||||
Selling, general and administrative expenses as a percentage of Net sales, non-GAAP | 34.4 | % | 34.0 | % | 40 | ||||||
Other (Income) Expense, Net | 2017 | 2016 | |||||||||
Other (income) expense, net, GAAP | $ | 114 | $ | 40 | |||||||
2012 Restructuring Program | (104 | ) | (33 | ) | |||||||
Other (income) expense, net, non-GAAP | $ | 10 | $ | 7 | |||||||
Operating Profit | 2017 | 2016 | % Change | ||||||||
Operating profit, GAAP | $ | 853 | $ | 944 | (10 | )% | |||||
2012 Restructuring Program | 142 | 59 | |||||||||
Operating profit, non-GAAP | $ | 995 | $ | 1,003 | (1 | )% | |||||
|
|||||||||||
Operating Profit Margin | 2017 | 2016 | Change | ||||||||
Operating profit margin, GAAP | 22.3 | % | 24.6 | % | (230 | ) | |||||
2012 Restructuring Program | 3.7 | % | 1.5 | % | |||||||
Operating profit margin, non-GAAP | 26.0 | % | 26.1 | % | (10 | ) |
Table 8 | |||||||||||||||||||||||||||
Continued | |||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||
Non-GAAP Reconciliations | |||||||||||||||||||||||||||
For the Three Months Ended |
|||||||||||||||||||||||||||
(Dollars in Millions Except Per Share Amounts) (Unaudited) | |||||||||||||||||||||||||||
2017 | |||||||||||||||||||||||||||
Net Income |
|||||||||||||||||||||||||||
Net Income |
Attributable |
||||||||||||||||||||||||||
Including |
To Colgate- |
Effective |
Diluted |
||||||||||||||||||||||||
Income Before |
Provision For |
Noncontrolling |
Palmolive |
Income |
Earnings |
||||||||||||||||||||||
Income Taxes |
Income Taxes(1) |
Interests |
Company |
Tax Rate(2) |
Per Share(3) |
||||||||||||||||||||||
As Reported GAAP | $ | 829 | $ | 269 | $ | 560 | $ | 524 | 32.4 | % | $ | 0.59 | |||||||||||||||
2012 Restructuring Program | 142 | 27 | 115 | 115 | (1.9 | )% | 0.13 | ||||||||||||||||||||
Non-GAAP | $ | 971 | $ | 296 | $ | 675 | $ | 639 | 30.5 | % | $ | 0.72 | |||||||||||||||
2016 | |||||||||||||||||||||||||||
Net Income |
|||||||||||||||||||||||||||
Income |
Provision |
Net Income |
Less: Income |
Attributable |
|||||||||||||||||||||||
Before |
For |
Including |
Attributable to |
To Colgate- |
Effective |
Diluted |
|||||||||||||||||||||
Income |
Income |
Noncontrolling |
Noncontrolling |
Palmolive |
Income |
Earnings |
|||||||||||||||||||||
Taxes |
Taxes(1) |
Interests |
Interests |
Company |
Tax Rate(2) |
Per Share(3) |
|||||||||||||||||||||
As Reported GAAP | $ | 919 | $ | 281 | $ | 638 | $ | 38 | $ | 600 | 30.6 | % | $ | 0.67 | |||||||||||||
2012 Restructuring Program | 59 | 14 | 45 | 1 | 44 | (0.4 | )% | 0.05 | |||||||||||||||||||
Benefit from a previously disclosed foreign tax matter, net | — | 13 | (13 | ) | — | (13 | ) | 1.3 | % | (0.01 | ) | ||||||||||||||||
Non-GAAP | $ | 978 | $ | 308 | $ | 670 | $ | 39 | $ | 631 | 31.5 | % | $ | 0.70 |
Notes: |
(1) The income tax effect on non-GAAP items is calculated based upon the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment. |
(2) The impact of non-GAAP items on the Company's effective tax rate represents the difference in the effective tax rate calculated with and without the non-GAAP adjustment on Income before income taxes and Provision for income taxes. |
(3) The impact of non-GAAP adjustments on Diluted earnings per share may not necessarily equal the difference between GAAP and non-GAAP as a result of rounding. |
Table 9 | |||||||||||
|
|||||||||||
Non-GAAP Reconciliations | |||||||||||
For the Six Months Ended |
|||||||||||
(Dollars in Millions Except Per Share Amounts) (Unaudited) | |||||||||||
Gross Profit | 2017 | 2016 | |||||||||
Gross profit, GAAP | $ | 4,569 | $ | 4,552 | |||||||
2012 Restructuring Program | 35 | 20 | |||||||||
Gross profit, non-GAAP | $ | 4,604 | $ | 4,572 | |||||||
|
|||||||||||
Gross Profit Margin | 2017 | 2016 | Change | ||||||||
Gross profit margin, GAAP | 60.2 | % | 59.8 | % | 40 | ||||||
2012 Restructuring Program | 0.5 | % | 0.3 | % | |||||||
Gross profit margin, non-GAAP | 60.7 | % | 60.1 | % | 60 | ||||||
Selling, General and Administrative Expenses | 2017 | 2016 | |||||||||
Selling, general and administrative expenses, GAAP | $ | 2,695 | $ | 2,674 | |||||||
2012 Restructuring Program | (38 | ) | (40 | ) | |||||||
Selling, general and administrative expenses, non-GAAP | $ | 2,657 | $ | 2,634 | |||||||
|
|||||||||||
Selling, General and Administrative Expenses as a Percentage of
|
2017 | 2016 | Change | ||||||||
Selling, general and administrative expenses as a percentage of Net sales, GAAP | 35.5 | % | 35.2 | % | 30 | ||||||
2012 Restructuring Program | (0.5 | )% | (0.6 | )% | |||||||
Selling, general and administrative expenses as a percentage of Net sales, non-GAAP | 35.0 | % | 34.6 | % | 40 | ||||||
Other (Income) Expense, Net | 2017 | 2016 | |||||||||
Other (income) expense, net, GAAP | $ | 136 | $ | 67 | |||||||
2012 Restructuring Program | (115 | ) | (54 | ) | |||||||
Other (income) expense, net, non-GAAP | $ | 21 | $ | 13 | |||||||
Operating Profit | 2017 | 2016 | % Change | ||||||||
Operating profit, GAAP | $ | 1,738 | $ | 1,811 | (4 | )% | |||||
2012 Restructuring Program | 188 | 114 | |||||||||
Operating profit, non-GAAP | $ | 1,926 | $ | 1,925 | — | % | |||||
|
|||||||||||
Operating Profit Margin | 2017 | 2016 | Change | ||||||||
Operating profit margin, GAAP | 22.9 | % | 23.8 | % | (90 | ) | |||||
2012 Restructuring Program | 2.5 | % | 1.5 | % | |||||||
Operating profit margin, non-GAAP | 25.4 | % | 25.3 | % | 10 | ||||||
Table 9 | |||||||||||||||||||||||||||
Continued | |||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||
Non-GAAP Reconciliations | |||||||||||||||||||||||||||
For the Six Months Ended |
|||||||||||||||||||||||||||
(Dollars in Millions Except Per Share Amounts) (Unaudited) | |||||||||||||||||||||||||||
2017 | |||||||||||||||||||||||||||
Net Income |
|||||||||||||||||||||||||||
Net Income |
Attributable |
||||||||||||||||||||||||||
Including |
To Colgate- |
Effective |
Diluted |
||||||||||||||||||||||||
Income Before |
Provision For |
Noncontrolling |
Palmolive |
Income |
Earnings |
||||||||||||||||||||||
Income Taxes |
Income Taxes(1) |
Interests |
Company |
Tax Rate(2) |
Per Share(3) |
||||||||||||||||||||||
As Reported GAAP | $ | 1,691 | $ | 520 | $ | 1,171 | $ | 1,094 | 30.8 | % | $ | 1.23 | |||||||||||||||
2012 Restructuring Program | 188 | 42 | 146 | 146 | (0.9 | )% | 0.16 | ||||||||||||||||||||
Non-GAAP | $ | 1,879 | $ | 562 | $ | 1,317 | $ | 1,240 | 29.9 | % | $ | 1.39 | |||||||||||||||
2016 | |||||||||||||||||||||||||||
Less: Income |
Net Income |
||||||||||||||||||||||||||
Income |
Provision |
Net Income |
Attributable |
Attributable |
|||||||||||||||||||||||
Before |
For |
Including |
To |
To Colgate- |
Effective |
Diluted |
|||||||||||||||||||||
Income |
Income |
Noncontrolling |
Noncontrolling |
Palmolive |
Income |
Earnings |
|||||||||||||||||||||
Taxes |
Taxes(1) |
Interests |
Interests |
Company |
Tax Rate(2) |
Per Share(3) |
|||||||||||||||||||||
As Reported GAAP | $ | 1,758 | $ | 546 | $ | 1,212 | $ | 79 | $ | 1,133 | 31.1 | % | $ | 1.26 | |||||||||||||
2012 Restructuring Program | 114 | 31 | 83 | 1 | 82 | (0.2 | )% | 0.09 | |||||||||||||||||||
Benefit from a previously disclosed foreign tax matter, net | — | 13 | (13 | ) | — | (13 | ) | 0.6 | % | (0.01 | ) | ||||||||||||||||
Non-GAAP | $ | 1,872 | $ | 590 | $ | 1,282 | $ | 80 | $ | 1,202 | 31.5 | % | $ | 1.33 |
Notes: |
(1) The income tax effect on non-GAAP items is calculated based upon the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment. |
(2) The impact of non-GAAP items on the Company's effective tax rate represents the difference in the effective tax rate calculated with and without the non-GAAP adjustment on Income before income taxes and Provision for income taxes. |
(3) The impact of non-GAAP adjustments on Diluted earnings per share may not necessarily equal the difference between GAAP and non-GAAP as a result of rounding. |
View source version on businesswire.com: http://www.businesswire.com/news/home/20170721005074/en/
or
Source:
News Provided by Acquire Media